Veritas Pharma Provides Corporate Update on Q1 2018

VANCOUVER, British Columbia, Feb. 21, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an official corporate update on its achievements, related scientific activities and growth strategies for...

Dr. Brian O’Connor Joins Veritas Pharma Advisory Board

VANCOUVER, British Columbia, Jan. 02, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor, a consultant in respiratory medicine, has joined its advisory board. He is a...

Veritas Pharma Issues Incentive Stock Options

December 21, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) announces the issuance of 2,350,000 stock options at $0.64 to directors, management, and consultants of the Company for a term of twelve...

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!